bf/NASDAQ:AMGN_icon.jpeg

NASDAQ:AMGN

Amgen Inc.

  • Stock

283.78

−2.45%

−18.16

USD last updated 05/08 01:57:14

Last Close

301.94

04/08 21:04

Market Cap

172.56B

Beta: 0.64

Volume Today

2.90M

Avg: 2.46M

PE Ratio

22.81

PFCF: 17.94

Dividend Yield

2.64%

Payout:58.90%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low w...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    123452017-04-262019-04-302021-04-272023-04-272024-10-30

    Revenue (Estimate*)

    2B4B6B8B2017-04-262019-04-302021-04-272023-04-272024-10-30

    *Estimate based on analyst consensus